High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients
Active, not recruiting · NCT05215327 · Registry updated 2026-09-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients | Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, infectious disease, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Active, not recruiting | Phase 2 | 2026-09-04 | NCT05215327 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor College of Medicine | 267 |
| Duke University | 446 |
| Emory University | 393 |
| Northwestern University | 381 |
| NYU Langone Health | 359 |
| University of Alabama at Birmingham | 467 |
| University of Washington | 397 |
| Vanderbilt University Medical Center | 299 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Vanderbilt University Medical Center | Nashville | United States | 427 |